Cargando…
Conserved statin-mediated activation of the p38-MAPK pathway protects Caenorhabditis elegans from the cholesterol-independent effects of statins
OBJECTIVE: Statins are a group of medications that reduce cholesterol synthesis by inhibiting the activity of HMG-CoA reductase, a key enzyme in the mevalonate pathway. The clinical use of statins to lower excess cholesterol levels has revolutionized the cardiovascular field and increased the surviv...
Autores principales: | Goncalves, Irina Langier, Tal, Sharon, Barki-Harrington, Liza, Sapir, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240216/ https://www.ncbi.nlm.nih.gov/pubmed/32339771 http://dx.doi.org/10.1016/j.molmet.2020.101003 |
Ejemplares similares
-
Cholesterol, Statins, and Alzheimer Disease
por: Koudinov, Alexei R, et al.
Publicado: (2005) -
A Decline in p38 MAPK Signaling Underlies Immunosenescence in Caenorhabditis elegans
por: Youngman, Matthew J., et al.
Publicado: (2011) -
Statins redux: A re-assessment of how statins lower plasma cholesterol
por: Raghow, Rajendra
Publicado: (2017) -
Phosphorylation of the Conserved Transcription Factor ATF-7 by PMK-1 p38 MAPK Regulates Innate Immunity in Caenorhabditis elegans
por: Shivers, Robert P., et al.
Publicado: (2010) -
Statins: Cholesterol guidelines and Indian perspective
por: Menon, Anil S., et al.
Publicado: (2015)